 Treating psychiatrists consider a candidate eligible for ECT and start pre-ECT investigations. The investigators screen all depressive ECT patients for inclusion in the study and ask for their informed consent IC. The treating psychiatrist decides when ECT is stopped considering clinical evolution and side effects. 